Exposure to PFAS: Navigating Carveouts, Exemptions, and Emerging Compliance Challenges

September 2, 2026 | 2:00PM–3:30PM ET | Live Webinar

Register Now Exposure to PFAS: Navigating Carveouts, Exemptions, and Emerging Compliance Challenges September 2, 2026, 2:00-3:30PM ET | Live Webinar
BUY NOW FDA and Medical Product Oversight: Assessing Recent Changes Recorded June 25, 2025 | On-Demand Webinar

Overview

Keep abreast of the evolving PFAS regulatory landscape in this expert-led webinar covering the latest legislative developments, including exemptions, carveouts, reporting requirements, and preemption. Panelists will explore the compliance implications of PFAS regulations across multiple layers of packaging as products move through the supply chain, providing practical guidance for industry. Don’t miss this opportunity to unravel the complex and ever-changing tapestry of PFAS legislation and proprietary chemistry.

$149

Members

$249

Non-Members

Speakers

Edward Margerrison
Read Bio
Director, Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), FDA

Michael M. Morton
Read Bio
Senior Policy Advisor, Medical Alley

Moderated By A.J. Wissinger
Read Bio
Partner, Reed Smith LLP

FDLI applies for CLE credits in Ohio and Virginia. These CLE approvals also may be honored by other states. The CLE credits will be posted as they are granted and registrants can request to be notified when approval is received.